These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 20021456
1. The effects of current therapies on airway remodeling in asthma and new possibilities for treatment and prevention. Royce SG, Tang ML. Curr Mol Pharmacol; 2009 Jun; 2(2):169-81. PubMed ID: 20021456 [Abstract] [Full Text] [Related]
2. Impact of inhaled corticosteroids and leukotriene receptor antagonists on airway remodeling. Hoshino M. Clin Rev Allergy Immunol; 2004 Aug; 27(1):59-64. PubMed ID: 15347851 [Abstract] [Full Text] [Related]
3. What effect does asthma treatment have on airway remodeling? Current perspectives. Durrani SR, Viswanathan RK, Busse WW. J Allergy Clin Immunol; 2011 Sep; 128(3):439-48; quiz 449-50. PubMed ID: 21752441 [Abstract] [Full Text] [Related]
4. Effect of intranasal rosiglitazone on airway inflammation and remodeling in a murine model of chronic asthma. Lee HY, Rhee CK, Kang JY, Park CK, Lee SY, Kwon SS, Kim YK, Yoon HK. Korean J Intern Med; 2016 Jan; 31(1):89-97. PubMed ID: 26767862 [Abstract] [Full Text] [Related]
5. The leukotriene receptor antagonist pranlukast attenuates airway remodeling by suppressing TGF-β signaling. Hur J, Kang JY, Rhee CK, Kim YK, Lee SY. Pulm Pharmacol Ther; 2018 Feb; 48():5-14. PubMed ID: 29031615 [Abstract] [Full Text] [Related]
6. Bidirectional interaction of airway epithelial remodeling and inflammation in asthma. Banno A, Reddy AT, Lakshmi SP, Reddy RC. Clin Sci (Lond); 2020 May 15; 134(9):1063-1079. PubMed ID: 32369100 [Abstract] [Full Text] [Related]
7. Effects of the histone deacetylase inhibitor, trichostatin A, in a chronic allergic airways disease model in mice. Royce SG, Dang W, Yuan G, Tran J, El-Osta A, Karagiannis TC, Tang ML. Arch Immunol Ther Exp (Warsz); 2012 Aug 15; 60(4):295-306. PubMed ID: 22684086 [Abstract] [Full Text] [Related]
9. Corticosteroids and antigen avoidance decrease airway smooth muscle mass in an equine asthma model. Leclere M, Lavoie-Lamoureux A, Joubert P, Relave F, Setlakwe EL, Beauchamp G, Couture C, Martin JG, Lavoie JP. Am J Respir Cell Mol Biol; 2012 Nov 15; 47(5):589-96. PubMed ID: 22721832 [Abstract] [Full Text] [Related]
10. Airway remodelling in asthma: current understanding and implications for future therapies. Tang ML, Wilson JW, Stewart AG, Royce SG. Pharmacol Ther; 2006 Nov 15; 112(2):474-88. PubMed ID: 16759709 [Abstract] [Full Text] [Related]
11. Spleen tyrosine kinase inhibition blocks airway constriction and protects from Th2-induced airway inflammation and remodeling. Tabeling C, Herbert J, Hocke AC, Lamb DJ, Wollin SL, Erb KJ, Boiarina E, Movassagh H, Scheffel J, Doehn JM, Hippenstiel S, Maurer M, Gounni AS, Kuebler WM, Suttorp N, Witzenrath M. Allergy; 2017 Jul 15; 72(7):1061-1072. PubMed ID: 27906453 [Abstract] [Full Text] [Related]
12. Protective effects of valproic acid against airway hyperresponsiveness and airway remodeling in a mouse model of allergic airways disease. Royce SG, Dang W, Ververis K, De Sampayo N, El-Osta A, Tang ML, Karagiannis TC. Epigenetics; 2011 Dec 15; 6(12):1463-70. PubMed ID: 22139576 [Abstract] [Full Text] [Related]
13. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model. Muz MH, Deveci F, Bulut Y, Ilhan N, Yekeler H, Turgut T. Exp Mol Med; 2006 Apr 30; 38(2):109-18. PubMed ID: 16672764 [Abstract] [Full Text] [Related]
14. Therapeutic effects of histone deacetylase inhibitors in a murine asthma model. Ren Y, Su X, Kong L, Li M, Zhao X, Yu N, Kang J. Inflamm Res; 2016 Dec 30; 65(12):995-1008. PubMed ID: 27565183 [Abstract] [Full Text] [Related]
15. Effect of peroxisome proliferator-activated receptor-gamma on airway smooth muscle thickening in a murine model of chronic asthma. Rhee CK, Lee SY, Kang JY, Kim SJ, Kwon SS, Kim YK, Park SH. Int Arch Allergy Immunol; 2009 Dec 30; 148(4):289-96. PubMed ID: 19001788 [Abstract] [Full Text] [Related]
16. Can anti-IgE therapy prevent airway remodeling in allergic asthma? Rabe KF, Calhoun WJ, Smith N, Jimenez P. Allergy; 2011 Sep 30; 66(9):1142-51. PubMed ID: 21645010 [Abstract] [Full Text] [Related]
17. A novel prostacyclin agonist protects against airway hyperresponsiveness and remodeling in mice. Yamabayashi C, Koya T, Kagamu H, Kawakami H, Kimura Y, Furukawa T, Sakagami T, Hasegawa T, Sakai Y, Matsumoto K, Nakayama M, Gelfand EW, Suzuki E, Narita I. Am J Respir Cell Mol Biol; 2012 Aug 30; 47(2):170-7. PubMed ID: 22403804 [Abstract] [Full Text] [Related]
18. [Future perspectives in the therapy of asthma in children]. Tosca MA, Villa E, Rossi GA. Minerva Pediatr; 2008 Apr 30; 60(2):235-47. PubMed ID: 18449140 [Abstract] [Full Text] [Related]
19. Inflammation and remodeling in the adult and child with asthma. Jeffery P. Pediatr Pulmonol Suppl; 2001 Apr 30; 21():3-16. PubMed ID: 11475169 [Abstract] [Full Text] [Related]
20. Review: Pharmacological treatment of airway remodeling: inhaled corticosteroids or antileukotrienes? Riccioni G, Di Ilio C, D'Orazio N. Ann Clin Lab Sci; 2004 Apr 30; 34(2):138-42. PubMed ID: 15228224 [Abstract] [Full Text] [Related] Page: [Next] [New Search]